Arkolith/Insider Trading/KLRS/Form 4

Hagen Brett R

Chief Accounting OfficerKalaris Therapeutics, Inc. (KLRS) · full profile →Form 4 · filed Mar 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2025Sell(S)907$8.97$8K2K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-046263) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML